Giuseppe Lungarella

Prof. Dr. Giuseppe Lungarella

University of Siena, Siena, Tuscany, Italy

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2004 in Mass Spectrometry Reviews
Verified
Journal Article
Closed access
PDF file
IDIsabella Dalle-Donne
Isabella Dalle-Donne
Andrea ScaloniAndrea Scaloni
Andrea Scaloni
Daniela GiustariniDaniela Giustarini
Daniela Giustarini
ECEleonora Cavarra
Eleonora Cavarra
Gianluca TellGianluca Tell
Gianluca Tell
AMAldo Milzani
Aldo Milzani

1 August 2010 in Pulmonary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
AHArmin Hatzelmann
Armin Hatzelmann
$M$%&Esteban Morcillo
$%&Esteban Morcillo
GLGiuseppe Lungarella
Giuseppe Lungarella
SASerge Adnot
Serge Adnot
SSShahin Sanjar
Shahin Sanjar
HTHermann Tenor
Hermann Tenor

1 May 2010 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
MLMarek Lommatzsch
Marek Lommatzsch
SCSanja Cicko
Sanja Cicko
TMTobias Müller
Tobias Müller
MLMonica Lucattelli
Monica Lucattelli
KBKai Bratke
Kai Bratke
MIMarco Idzko
Marco Idzko
Rationale: Extracellular ATP promotes inflammation, but its role in chronic obstructive pulmonary disease (COPD) is unknown. Objectives: To analyze the expression of ATP and its functional consequences in never-smokers, asymptomatic smokers, and patients with COPD. Methods: ATP was quantified in bronchoalveolar lavage fluid (BALF) of never-smokers, asymptomatic smokers, and patients with COPD of different severity. The expression of specific ATP (purinergic) receptors was measured in airway macrophages and blood neutrophils from control subjects and patients with COPD. The release of mediators by macrophages and neutrophils and neutrophil chemotaxis was assessed after ATP stimulation. Measurements and Main Results: Chronic smokers had elevated ATP concentrations in BALF compared with never-smokers. Acute smoke exposure led to a further increase in endobronchial ATP concentrations. Highest ATP concentrations in BALF were present in smokers and ex-smokers with COPD. In patients with COPD, BALF ATP concentrations correlated negatively with lung function and positively with BALF neutrophil counts. ATP induced a stronger chemotaxis and a stronger elastase release in blood neutrophils from patients with COPD, as compared with control subjects. In addition, airway macrophages from patients with COPD responded with an increased secretion of proinflammatory and tissue-degrading mediators after ATP stimulation. These findings were accompanied by an up-regulation of specific purinergic receptors in blood neutrophils and airway macrophages of patients with COPD. Conclusions: COPD is characterized by a strong and persistent up-regulation of extracellular ATP in the airways. Extracellular ATP appears to contribute to the pathogenesis of COPD by promoting inflammation and tissue degradation.

1 October 2005 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
PMPiero A. Martorana
Piero A. Martorana
RBRolf Beume
Rolf Beume
MLMonica Lucattelli
Monica Lucattelli
LWLutz Wollin
Lutz Wollin
GLGiuseppe Lungarella
Giuseppe Lungarella
Rationale: There is a need for new agents capable of suppressing the inflammatory response in chronic obstructive pulmonary disease. Objectives: This study evaluated the effects of roflumilast, a phosphodiesterase 4 (PDE4) inhibitor on acute lung inflammation and chronic lung changes in models of cigarette exposure in mice. Methods: Roflumilast was given orally either at 1 mg/kg (R1) or at 5 mg/kg (R5). In the acute model (five cigarettes for 20 minutes), bronchoalveolar lavage fluid (BALF) changes were investigated at 4 and 24 hours. In the chronic model (three cigarettes/day for 7 months), morphometric and biochemical parameters were assessed at 7 months. Measurements and Main Results: Acute exposure caused a fivefold increase in BALF neutrophils. Both doses of roflumilast partially prevented (by 30%) this increase. In addition, after smoke exposure, R1 increased BALF interleukin-10 by 79% and R5 by 129%. Chronic smoke exposure caused a 1.8-fold increase in lung macrophage density, emphysema, an increase of the mean linear intercept (+21%), a decrease of the internal surface area (−13%), and a drop (−13%) in lung desmosine content. R1 did not have any effect, whereas R5 prevented the increase in lung macrophage density by 70% and fully prevented the other changes. In addition, in the smoke-exposure group, 63% of the mice showed goblet cell metaplasia, and neither of the doses of roflumilast had any effect. Conclusions: This study shows for the first time that a PDE4 inhibitor partially ameliorates lung inflammation and fully prevents parenchymal destruction induced by cigarette smoke.

1 August 1998 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
PDF file
JLJoseph A. Lasky
Joseph A. Lasky
LOLuis A. Ortiz
Luis A. Ortiz
BTBoihoang Tonthat
Boihoang Tonthat
GHGary W. Hoyle
Gary W. Hoyle
MCMiriam Corti
Miriam Corti
MFMitchell Friedman
Mitchell Friedman
Connective tissue growth factor (CTGF) is a newly described 38-kDa peptide mitogen for fibroblasts and a promoter of connective tissue deposition in the skin. TheCTGF gene promotor contains a transforming growth factor-β1 (TGF-β1) response element. Because TGF-β1 expression is upregulated in several models of fibroproliferative lung disease, we asked whether CTGF is also upregulated in a murine lung fibrosis model and whether CTGF could mediate some of the fibrogenic effects associated with TGF-β1. A portion of the rat CTGF gene was cloned and used to show that primary isolates of both murine and human lung fibroblasts express CTGF mRNA in vitro. There was a greater than twofold increase in CTGF expression in both human and murine lung fibroblasts 2, 4, and 24 h after the addition of TGF-β1 in vitro. A bleomycin-sensitive mouse strain (C57BL/6) and a bleomycin-resistant mouse strain (BALB/c) were given bleomycin, a known lung fibrogenic agent. CTGF mRNA expression was upregulated in the sensitive, but not in the resistant, mouse strain after administration of bleomycin. In vivo differences in the CTGF expression between the two mouse strains were not due to an inherent inability of BALB/c lung fibroblasts to respond to TGF-β1 because fibroblasts from untreated BALB/c mouse lung upregulated their CTGF message when treated with TGF-β1 in vitro. These data demonstrate that CTGF is expressed in lung fibroblasts and may play a role in the pathogenesis of lung fibrosis.

1 January 2005 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
BBB. Bartalesi
B. Bartalesi
ECEleonora Cavarra
Eleonora Cavarra
SFS. Fineschi
S. Fineschi
MLM. Lucattelli
M. Lucattelli
BLB. Lunghi
B. Lunghi
GLGiuseppe Lungarella
Giuseppe Lungarella
The development of cigarette smoke-induced pulmonary changes in C57 Bl/6J and DBA/2 mice was investigated. Both strains are sensitive to oxidants and C57Bl/6J mice are moderately deficient in serum alpha1-proteinase inhibitor.Following chronic exposure to cigarette smoke, patchy emphysema was present in mice of both strains, but developed faster in DBA/2 mice. A positive reaction for mouse neutrophil elastase was seen on the septa of both strains. Additionally, the DBA/2 mice developed a uniform parenchymal dilation that was preceded by the appearance of apoptotic cells in areas with a low signal for vascular endothelial growth factor-receptor 2. Fibrotic areas scattered throughout the parenchyma, coupled with a positive immunohistochemical reaction for transforming growth factor-β was seen only in DBA/2 mice.Both DBA/2 and C57Bl/6J strains showed epithelial cell injury and areas of deciliation in their airways. However, the appearance of goblet cell metaplasia was common in C57Bl/6J mice but rare in DBA/2 mice. A positive immunohistochemical reaction for interleukin (IL)-4, IL-13 and MUC5AC was seen only in the airways of C57Bl/6J mice.Strain characteristics (alpha1-proteinase inhibitor levels, sensitivity to oxidants, and constitutive levels of vascular endothelial growth factor-receptor 2) and phenotypical responses (apoptosis and cytokine distribution) may condition parenchymal and airway changes to cigarette smoke.